What's more, Nrf2 not only balances oxidative stress, but also negatively affects TGF-β-mediated pro-fibrogenic signaling [15, 16], which suggests that Nrf2 could be a potential target for anti-liver fibrosis strategies. The gene discussed is NFE2L2; the disease is Hepatic fibrosis.